Kirchgraber Paul R

CEO, Covance Drug Development

1 company

Holdings by Company

LH2023-05-19

Current Shares12.9K

Est. Value$2.81M

Net Activity-12,300

Bought: 0Sold: 12.3K

Showing 2 transactions

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	SEC
2023-05-19	LH	CEO, Covance Drug Development	Sale+OE	4,300	$216.91	$932,706.98	-24.9%	→
2023-02-21	LH	CEO, Covance Drug Development	Sale+OE	8,000	$250.58	$2,004,675.20	-46.9%	→